Genomic evidence for recent positive selection at the human MDR1 gene locus

Human Molecular Genetics

Volumn 13, Issue 8, 2004, Pages 783-797

  Tang, Kun ^a   Wong, Li Peng ^a   See, Edmund J D ^a   Chong, Samuel S ^a,c   Lee, Caroline G L ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1;

AFRICAN AMERICAN; ALLELE; ARTICLE; ASIAN; CAUCASIAN; CHINESE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; EVOLUTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENE STRUCTURE; GENETIC SELECTION; GENETIC VARIABILITY; HAPLOTYPE; HISTORY; HUMAN; INDIAN; POPULATION MODEL; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

DRUG RESISTANCE, MULTIPLE; GENE FREQUENCY; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; SELECTION (GENETICS); SEQUENCE ANALYSIS, DNA;

EID: 1942421704     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh099     Document Type: Article

References (59)

1. Juliano, R.L. and Ling, V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 455, 152-162.
2. Schwab, M., Eichelbaum, M. and Fromm, M.F. (2003) Genetic polymorphisms of the human mdr1 drug transporter. A. Rev. Pharmac. Toxicol., 43, 285-307.
3. Lee, C.G., Gottesman, M.M., Cardarelli, C.O., Ramachandra, M., Jeang, K.T., Ambudkar, S.V., Pastan, I. and Dey, S. (1998) HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry, 37, 3594-3601.
4. Lee, C.G. and Gottesman, M.M. (1998) HIV-1 protease inhibitors and the MDR1 multidrug transporter. [Editorial.] J. Clin. Invest., 101, 287-288.
5. Sharom, F.J., DiDiodato, G., Yu, X. and Ashbourne, K.J. (1995) Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores. J. Biol. Chem., 270, 10334-10341.
6. Ueda, K., Taguchi, Y. and Morishima, M. (1997) How does P-glycoprotein recognize its substrates? Semin. Cancer Biol., 8, 151-159.
7. Lee, C.G., Ramachandra, M., Jeang, K.T., Martin, M.A., Pastan, I. and Gottesman, M.M. (2000) Effect of ABC transporters on HIV-1 infection: inhibition of virus production by the MDR1 transporter. FASEB J., 14, 516-522.
8. Raviv, Y., Puri, A. and Blumenthal, R. (2000) P-glycoprotein-overexpressing multidrug-resistant cells are resistant to infection by enveloped viruses that enter via the plasma membrane. FASER J., 14, 511-515.
9. Borst, P. and Schinkel, A.H. (1996) What have we learnt thus far from mice with disrupted P-glycoprotein genes? Eur. J. Cancer, 32A, 985-990.
10. Schinkel, A.H., Wagenaar, E., Mol, C.A. and van Deemter, L. (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest., 97, 2517-2524.
11. Lankas, G.R., Wise, L.D., Cartwright, M.E., Pippert, T. and Umbenhauer, D.R. (1998) Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod. Toxicol., 12, 457-463.
12. Tang, K., Ngoi, S.M., Gwee, P.C., Chua, J.M.Z., Lee, E.J.D., Chong, S.C. and Lee, C.G.L. (2002) Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics, 12, 437-450.
13. Kim, R.B., Leake, B.F., Choo, E.F., Dresser, G.K., Kubba, S.V., Schwarz, U.I., Taylor, A., Xie, H.G., McKinsey, J., Zhou, S. et al. (2001) Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmac. Ther., 70, 189-199.
14. Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H.P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M. et al. (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl Acad. Sci. USA, 97, 3473-3478.
15. Hitzl, M., Drescher, S., van der Kuip, H., Schaffeler, E., Fischer, J., Schwab, M., Eichelbaum, M. and Fromm, M.F. (2001) The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics, 11, 293-298.
16. Fellay, J., Marzolini, C., Meadon, E., Back, D., Buclin, T., Chave, J., Decosterd, L., Furrer, H., Opravil, M., Pantaleo, G. et al. (2002) Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter I: a pharmacogenetic study. Lancet, 359, 30-36.
17. Tanabe, M., Ieiri, I., Nagata, N., Inoue, K., Ito, S., Kanamori, Y., Takahashi, M., Kurata, Y., Kigawa, J., Higuchi, S. et al. (2001) Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J. Pharmac. Exp. Ther., 297, 1137-1143.
18. Siegmund, W., Ludwig, K., Giessmann, T., Dazert, P., Schroeder, E., Sperker, B., Warzok, R., Kroemer, H.K. and Cascorbi, I. (2002) The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol. Clin. Pharmac. Ther., 72, 572-583.
19. Moriya, Y., Nakamura, T., Hormouchi, M., Sakaeda, T., Tamura, T., Aoyama, N., Shirakawa, T., Gotoh, A., Fujimoto, S., Matsuo, M. et al. (2002) Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects. Biol. Pharm. Bull., 25, 1356-1359.
20. Siegsmund, M., Brinkmann, U., Schaffeler, E., Weirich, G., Schwab, M., Eichelbaum, M., Fritz, P., Burk, O., Decker, J., Alken, P. et al. (2002) Association of the P-glycoprotein transporter MDR1 (C3435T) polymorphism with the susceptibility to renal epithelial tumors. J. Am. Soc. Nephrol., 13, 1847-1854.
21. van den Heuvel-Eibrink, M.M., Wiemer, E.A., de Boevere, M.J., van der Holt, B., Vossebeld, P.J., Pieters, R. and Sonneveld, P. (2001) MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia. Blood, 97, 3605-3611.
22. Kimchi-Sarfaty, C., Gribar, J.J. and Gottesman, M.M. (2002) Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. Mol. Pharmacol., 62, 1-6.
23. Roberts, R., Joyce, P., Mulder, R., Begg, E. and Kennedy, M. (2002) A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated with major depression. Pharmacogenomics, 2, 191-196.
24. Sakaeda, T., Nakamura, T., Horinouchi, M., Kakumoto, M., Ohmoto, N., Sakai, T., Morita, Y., Tamura, T., Aoyama, N., Hirai, M. et al. (2001) MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharm. Res., 18, 1400-1404.
25. Gerloff, T., Schaefer, M., Johne, A., Oselin, K., Meisel, C., Cascorbi, I. and Roots, I. (2002) MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males. Br. J. Clin. Pharmacol., 54, 610-616.
26. Ifergan, I., Bernard, N.F., Bruneau, J., Alary, M., Tsoukas, C.M. and Roger, M. (2002) Allele frequency of three functionally active polymorphisms of the MDR- 1 gene in high-risk HIV-negative and HIV-positive Caucasians. AIDS, 16, 2340-2342.
27. Johne, A., Kopke, K., Gerloff, T., Mai, I., Rietbrock, S., Meisel, C., Hoffmeyer, S., Kerb, R., Fromm, M.F., Brinkmann, U. et al. (2002) Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene. Clin. Pharmac. Ther., 72, 584-594.
28. Drescher, S., Schaeffeler, E., Hitzl, M., Hofmann, U., Schwab, M., Brinkmann, U., Eichelbaum, M. and Fromm, M.F. (2002) MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br. J. Clin. Pharmac., 53, 526-534.
29. Kerb, R., Aynacioglu, A.S., Brockmoller, J., Schlagenhaufer, R., Bauer, S., Szekeres, T., Hamwi, A., Fritzer-Szekeres, M., Baumgartner, C., Ongen, H.Z. et al. (2001) The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels. Pharmacogenom. J., 1, 204-210.
30. Zheng, H., Webber, S., Zeevi, A., Schuetz, E., Zhang, J., Bowman, P., Boyle, G., Law, Y., Miller, S., Lamba, J. et al. (2003) Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am. J. Transplant., 3, 477-483.
31. Siddiqui, A., Kerb, R., Weale, M.E., Brinkmann, U., Smith, A., Goldstein, D.B., Wood, N.W. and Sisodiya, S.M. (2003) Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. New Engl. J. Med., 348, 1442-1448.
32. Zheng, H., Webber, S., Zeevi, A., Schuetz, E., Zhang, J., Lamba, J., Bowman, P. and Burckart, G.J. (2002) The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients. Hum. Immunol., 63, 765-770.
33. Yamauchi, A., Ieiri, I., Kataoka, Y., Tanabe, M., Nishizaki, T., Oishi, R., Higuchi, S., Otsubo, K. and Sugimachi, K. (2002) Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. Transplantation, 74, 571-572.
34. Drozdzik, M., Bialecka, M., Mysliwiec, K., Honczarenko, K., Stankiewicz, J. and Sych, Z. (2003) Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics, 13, 259-263.
35. Schwab, M., Schaeffeler, E., Marx, C., Fromm, M.F., Kaskas, B., Metzler, J., Stange, E., Herfarth, H., Schoelmerich, J., Gregor, M. et al. (2003) Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology, 124, 26-33.
36. Furuno, T., Landi, M.T., Ceroni, M., Caporaso, N., Bernucci, I., Nappi, G., Martignoni, E., Schaeffeler, E., Eichelbaum, M., Schwab, M. et al. (2002) Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics, 12, 529-534.
37. Illmer, T., Schuler, U.S., Thiede, C., Schwarz, U.I., Kim, R.B., Gotthard, S., Freund, D., Schakel, U., Ehninger, G. and Schaich, M. (2002) MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res., 62, 4955-4962.
38. Haga, H., Yamada, R., Ohnishi, Y., Nakamura, Y. and Tanaka, T. (2002) Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. Single-nucleotide polymorphism. J. Hum. Genet., 47, 605-610.
39. Ito, S., Ieiri, I., Tanabe, M., Suzuki, A., Higuchi, S. and Otsubo, K. (2001) Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics, 11, 175-184.
40. Bonnen, P.E., Wang, P.J., Kimmel, M., Chakraborty, R. and Nelson, D.L. (2002) Haplotype and linkage disequilibrium architecture for human cancer-associated genes. Genome Res., 12, 1846-1853.
41. Shifman, S., Kuypers, J., Kokoris, M., Yakir, B. and Darvasi, A. (2003) Linkage disequilibrium patterns of the human genome across populations. Hum. Mol. Genet., 12, 771-776.
42. Ardlie, K.G., Kruglyak, L. and Seielstad, M. (2002) Patterns of linkage disequilibrium in the human genome. Nat. Rev. Genet., 3, 299-309.
43. Sabeti, P.C., Reich, D.E., Higgins, J.M., Levine, H.Z., Richter, D.J., Schaffner, S.F., Gabriel, S.B., Platko, J.V., Patterson, N.J., McDonald, G.J. et al. (2002) Detecting recent positive selection in the human genome from haplotype structure. Nature, 419, 832-837.
44. Hammer, M.F. (1995) A recent common ancestry for human Y chromosomes. Nature, 378, 376-378.
45. Ingman, M., Kaessmann, H., Paabo, S. and Gyllensten, U. (2000) Mitochondrial genome variation and the origin of modern humans. Nature, 408, 708-713.
46. Krings, M., Stone, A., Schmitz, R.W., Krainitzki, H., Stoneking, M. and Paabo, S. (1997) Neandertal DNA sequences and the origin of modern humans. Cell, 90, 19-30.
47. Abecasis, G.R., Noguchi, E., Heinzmann, A., Traherne, J.A., Bhattacharyya, S., Leaves, N.I., Anderson, G.G., Zhang, Y., Lench, N.J., Carey, A. et al. (2001) Extent and distribution of linkage disequilibrium in three genomic regions. Am. J. Hum. Genet., 68, 191-197.
48. Bonnen, P.E., Story, M.D., Ashorn, C.L., Buchholz, T.A., Weil, M.M. and Nelson, D.L. (2000) Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium. Am. J. Hum. Genet., 67, 1437-1451.
49. Stephens, J.C., Schneider, J.A., Tanguay, D.A., Choi, J., Acharya, T., Stanley, S.F., Jiang, R., Messer, C.J., Chew, A., Han, J.H. et al. (2001) Haplotype variation and linkage disequilibrium in 313 human genes. Science, 293, 489-493.
50. Zhu, X., Yan, D., Cooper, R.S., Luke, A., Ikeda, M.A., Chang, Y.P., Weder, A. and Chakravarti, A. (2003) Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program. Genome Res., 13, 173-181.
51. Reich, D.E., Cargill, M., Bolk, S., Ireland J., Sabeti, P.C., Richter, D.J., Lavery, T., Kouyoumjian, R., Farhadian, S.F., Ward, R. et al. (2001) Linkage disequilibrium in the human genome. Nature, 411, 199-204.
52. Lee, C.G.L., Tang, K., Cheung, Y.B., Wong, L.P., Tan, C., Shen, H., Zhao, Y., Pavanni, R., Lee, E.J.D., Wong, M.C. et al. (2004) MDR1, the blood-brain-barrier transporter is associated with Parkinson's disease in ethnic chinese. J. Med. Genet., in press.
53. Gwee, P.C., Tang, K., Chua, J.M., Lee, E.J., Chong, S.S. and Lee, C.G. (2003) Simultaneous genotyping of seven single-nucleotide polymorphisms in the MDR1 gene by single-tube multiplex minisequencing. Clin. Chem., 49, 672-676.
54. Excoffier, L. and Slatkin, M. (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol., 12, 921-927.
55. Lewontin, R.C. (1974) Annotation: the analysis of variance and the analysis of causes. Am. J. Hum. Genet., 26, 400-411.
56. Pritchard, J.K. and Przeworski, M. (2001) Linkage disequilibrium in humans: models and data. Am. J. Hum. Genet., 69, 1-14.
57. Schulze, T.G., Chen, Y.S., Akula, N., Hennessy, K., Badner, J.A., McInnis, M.G., DePaulo, J.R., Schumacher, J., Cichon, S., Propping, P. et al. (2002) Can long-range microsatellite data be used to predict short-range linkage disequilibrium? Hum. Mol. Genet., 11, 1363-1372.
58. Hudson, R.R. (2002) Generating samples under a Wright-Fisher neutral model of genetic variation. Bioinformatics, 18, 337-338.
59. Yu, A., Zhao, C., Fan, Y., Jang, W., Mungall, A.J., Deloukas, P., Olsen, A., Doggett, N.A., Ghebranious, N., Broman, K.W. et al. (2001) Comparison of human genetic and sequence-based physical maps. Nature, 409, 951-953.